Hudson Bay Capital Management’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-45,000
Closed -$4.58M 1006
2021
Q2
$4.58M Buy
45,000
+20,000
+80% +$2.03M 0.06% 381
2021
Q1
$2.52M Sell
25,000
-60,000
-71% -$6.15M 0.03% 485
2020
Q4
$9.35M Sell
85,000
-55,830
-40% -$5.93M 0.1% 124
2020
Q3
$14.8M Sell
140,830
-25,000
-15% -$2.59M 0.22% 77
2020
Q2
$16.9M Buy
165,830
+35,207
+27% +$3.5M 0.3% 54
2020
Q1
$12.8M Buy
+130,623
New +$12.9M 0.32% 57

Other funds holding CELU

Hudson Bay Capital Management's CELU Position: Q3 2021 in Review

Hudson Bay Capital Management sold out of Celularity (CELU) in Q3 2021, closing a stake of 45,000 shares — an estimated $4.58M sold.

Hudson Bay Capital Management first reported a position in CELU in Q1 2020 and held it in 6 quarters. The position peaked at $16.9M in Q2 2020. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Hudson Bay Capital Management reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Hudson Bay Capital Management sold 45,000 Celularity shares in Q3 2021, an estimated $4.58M.
  • Hudson Bay Capital Management first reported a position in Celularity in Q1 2020 and held it in 6 quarters.
  • Hudson Bay Capital Management's Celularity position peaked at $16.9M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Hudson Bay Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.